Global Glucagon Injection Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
Description
According to our (Global Info Research) latest study, the global Glucagon Injection market size was valued at US$ 662 million in 2024 and is forecast to a readjusted size of USD 988 million by 2031 with a CAGR of 6.0% during review period.
Glucagon is a metabolic hormone secreted by the pancreas that raises blood glucose levels by causing the liver to rapidly convert glycogen (the stored form of glucose) into glucose, which is then released into the bloodstream. Glucagon and insulin are two critical hormones in a glycemic control system that keeps blood glucose at the right level in healthy individual. Glucagon is a medicine which used to treat severe low blood sugar (hypoglycemia). Glucagon works by telling your body to release sugar (glucose) into the bloodstream to bring the blood sugar level back up.
The Glucagon injection market is driven by the rising prevalence of diabetes and hypoglycemia, and the growing awareness of the importance of emergency treatment for severe low blood sugar episodes. Glucagon injections are life-saving emergency medications used to rapidly raise blood sugar levels in individuals experiencing severe hypoglycemia. The rise in the global diabetic population and the need for effective management of insulin-related conditions contribute to market growth as glucagon injections offer a crucial solution in emergency situations. Moreover, advancements in device design and the development of user-friendly glucagon delivery systems have improved the accessibility and ease of administration. However, the market also faces challenges, including the need for patient education on proper administration and storage of glucagon injections, and the complexity of the regulatory landscape for medical emergency medications. Additionally, addressing affordability and expanding access to glucagon injections in various regions can pose obstacles for manufacturers. To succeed, companies must focus on research and development to offer innovative and reliable glucagon injection solutions, collaborate with healthcare providers to promote awareness and training, and address the challenges to meet the increasing demand for effective and life-saving emergency treatments for hypoglycemia.
This report is a detailed and comprehensive analysis for global Glucagon Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Glucagon Injection market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Glucagon Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Glucagon Injection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Glucagon Injection market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Glucagon Injection
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Glucagon Injection market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novo Nordisk, Eli Lilly, Fresenius Kabi, Torrent Labs, Amphastar Pharmaceuticals, Xeris Pharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Glucagon Injection market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Vials
Prefilled
Market segment by Application
Hospital
Pharmacy
Major players covered
Novo Nordisk
Eli Lilly
Fresenius Kabi
Torrent Labs
Amphastar Pharmaceuticals
Xeris Pharmaceuticals
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Glucagon Injection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Glucagon Injection, with price, sales quantity, revenue, and global market share of Glucagon Injection from 2020 to 2025.
Chapter 3, the Glucagon Injection competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Glucagon Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Glucagon Injection market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Glucagon Injection.
Chapter 14 and 15, to describe Glucagon Injection sales channel, distributors, customers, research findings and conclusion.
Glucagon is a metabolic hormone secreted by the pancreas that raises blood glucose levels by causing the liver to rapidly convert glycogen (the stored form of glucose) into glucose, which is then released into the bloodstream. Glucagon and insulin are two critical hormones in a glycemic control system that keeps blood glucose at the right level in healthy individual. Glucagon is a medicine which used to treat severe low blood sugar (hypoglycemia). Glucagon works by telling your body to release sugar (glucose) into the bloodstream to bring the blood sugar level back up.
The Glucagon injection market is driven by the rising prevalence of diabetes and hypoglycemia, and the growing awareness of the importance of emergency treatment for severe low blood sugar episodes. Glucagon injections are life-saving emergency medications used to rapidly raise blood sugar levels in individuals experiencing severe hypoglycemia. The rise in the global diabetic population and the need for effective management of insulin-related conditions contribute to market growth as glucagon injections offer a crucial solution in emergency situations. Moreover, advancements in device design and the development of user-friendly glucagon delivery systems have improved the accessibility and ease of administration. However, the market also faces challenges, including the need for patient education on proper administration and storage of glucagon injections, and the complexity of the regulatory landscape for medical emergency medications. Additionally, addressing affordability and expanding access to glucagon injections in various regions can pose obstacles for manufacturers. To succeed, companies must focus on research and development to offer innovative and reliable glucagon injection solutions, collaborate with healthcare providers to promote awareness and training, and address the challenges to meet the increasing demand for effective and life-saving emergency treatments for hypoglycemia.
This report is a detailed and comprehensive analysis for global Glucagon Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Glucagon Injection market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Glucagon Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Glucagon Injection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Glucagon Injection market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Glucagon Injection
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Glucagon Injection market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novo Nordisk, Eli Lilly, Fresenius Kabi, Torrent Labs, Amphastar Pharmaceuticals, Xeris Pharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Glucagon Injection market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Vials
Prefilled
Market segment by Application
Hospital
Pharmacy
Major players covered
Novo Nordisk
Eli Lilly
Fresenius Kabi
Torrent Labs
Amphastar Pharmaceuticals
Xeris Pharmaceuticals
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Glucagon Injection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Glucagon Injection, with price, sales quantity, revenue, and global market share of Glucagon Injection from 2020 to 2025.
Chapter 3, the Glucagon Injection competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Glucagon Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Glucagon Injection market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Glucagon Injection.
Chapter 14 and 15, to describe Glucagon Injection sales channel, distributors, customers, research findings and conclusion.
Table of Contents
91 Pages
- 1 Market Overview
- 2 Manufacturers Profiles
- 3 Competitive Environment: Glucagon Injection by Manufacturer
- 4 Consumption Analysis by Region
- 5 Market Segment by Type
- 6 Market Segment by Application
- 7 North America
- 8 Europe
- 9 Asia-Pacific
- 10 South America
- 11 Middle East & Africa
- 12 Market Dynamics
- 13 Raw Material and Industry Chain
- 14 Shipments by Distribution Channel
- 15 Research Findings and Conclusion
- 16 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
